1. Home
  2. PFBC vs EVO Comparison

PFBC vs EVO Comparison

Compare PFBC & EVO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

PFBC

Preferred Bank

HOLD

Current Price

$94.51

Market Cap

1.1B

Sector

Finance

ML Signal

HOLD

Logo Evotec SE

EVO

Evotec SE

HOLD

Current Price

$3.31

Market Cap

1.1B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
PFBC
EVO
Founded
1991
1993
Country
United States
Germany
Employees
N/A
N/A
Industry
Major Banks
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.1B
1.1B
IPO Year
1998
2021

Fundamental Metrics

Financial Performance
Metric
PFBC
EVO
Price
$94.51
$3.31
Analyst Decision
Hold
Strong Buy
Analyst Count
3
1
Target Price
$104.67
$7.00
AVG Volume (30 Days)
69.2K
99.6K
Earning Date
10-20-2025
11-05-2025
Dividend Yield
3.18%
N/A
EPS Growth
N/A
N/A
EPS
9.87
N/A
Revenue
$271,347,000.00
$887,396,457.00
Revenue This Year
$3.09
N/A
Revenue Next Year
$3.60
$10.78
P/E Ratio
$9.57
N/A
Revenue Growth
4.21
N/A
52 Week Low
$71.90
$2.84
52 Week High
$99.45
$5.10

Technical Indicators

Market Signals
Indicator
PFBC
EVO
Relative Strength Index (RSI) 60.85 49.54
Support Level $88.89 $2.89
Resistance Level $96.00 $3.24
Average True Range (ATR) 1.88 0.09
MACD 0.40 0.04
Stochastic Oscillator 77.50 95.65

Price Performance

Historical Comparison
PFBC
EVO

About PFBC Preferred Bank

Preferred Bank is a commercial bank located in California. Its products and services are divided into Personal Banking, Business Banking, and Commercial Banking which includes Checking accounts, Savings accounts, CDs, Loans and Credit, Electronic banking, and Treasury Management. It provides personalized deposit services, real estate finance, commercial loans, and trade finance credit facilities to small and mid-sized businesses and their owners, entrepreneurs, real estate developers and investors, professionals, and high-net-worth individuals. The bank generates a majority of its revenue from Southern and Northern California and Flushing.

About EVO Evotec SE

Evotec is a drug discovery partnership firm providing solutions to pharmaceutical and biotechnology companies, academic institutions, foundations, and nonprofit organizations. The company offers services in a variety of therapeutic areas, including central nervous system disorders, diabetes, inflammation, oncology, infectious diseases, and women's health. The shared R&D segment, roughly 80% of sales, provides drug discovery and manufacturing services on a typical fee-for-service basis and integrated drug discovery collaborations based on its proprietary, internally developed assets. The Just-Evotec Biologics segment, about 20% of sales, offers CDMO services for biologics. As of 2023, the company has over 5,000 employees and 18 production sites mainly in Europe and the United States.

Share on Social Networks: